- Início
- Euronext Bruxelas
- Company regulated news
- Archive
- Company press releases
Company press releases
Released | Company | Title | Industry | Topic |
---|---|---|---|---|
29 Jan 2024 18:00 CET |
VAN DE VELDE | VAN DE VELDE : inkoop eigen aandelen | 40204020 Clothing and Accessories | Other subject |
29 Jan 2024 17:45 CET |
KINEPOLIS GROUP | Update inkoopprogramma eigen aandelen (29 januari 2024) | 40301010 Entertainment | Corporate life |
29 Jan 2024 17:45 CET |
KINEPOLIS GROUP | Update share buyback program (29 January 2024) | 40301010 Entertainment | Corporate life |
29 Jan 2024 17:45 CET |
KINEPOLIS GROUP | Mise à jour concernant le programme de rachat d'actions propres (29 janvier 2024) | 40301010 Entertainment | Corporate life |
29 Jan 2024 14:00 CET |
ONTEX GROUP | Ontex announces details for its Q4 and full year 2023 results publication | 45201020 Personal Products | Meetings / events |
29 Jan 2024 14:00 CET |
ONTEX GROUP | Ontex kondigt details aan voor de resultatenpublicatie van het volledige jaar en 4de kwartaal van 2023 | 45201020 Personal Products | Meetings / events |
29 Jan 2024 12:00 CET |
ORANGE BELGIUM | Orange Belgium nodigt investeerders en analisten uit om deel te nemen aan een online web en/of audio conferentie op 9 februari 2023 n.a.v. de resultaten van de tweede jaarhelft en het volledige jaar van 2023 | 15102015 Telecommunications Services | - |
29 Jan 2024 12:00 CET |
ORANGE BELGIUM | Orange Belgium invites investors and analysts to participate in its H2 and full year 2023 results online web conference and audio conference call on February 9, 2024 | 15102015 Telecommunications Services | - |
29 Jan 2024 12:00 CET |
ORANGE BELGIUM | Orange Belgium invite les investisseurs et les analystes à prendre part à la conférence en ligne et/ou téléphonique organisée le 9 février 2024 dans le cadre de ses résultats du second semestre et de l’exercice 2023 | 15102015 Telecommunications Services | - |
29 Jan 2024 08:22 CET |
TITAN CEMENT | Programme de rachat d'actions | 50101030 Cement | Other subject |
29 Jan 2024 08:20 CET |
TITAN CEMENT | Share buyback Programme | 50101030 Cement | Other subject |
29 Jan 2024 07:27 CET |
JENSEN-GROUP | Inkoop eigen aandelen - wekelijkse update | 50204000 Machinery: Industrial | Other subject |
29 Jan 2024 07:27 CET |
JENSEN-GROUP | Share buyback – weekly update | 50204000 Machinery: Industrial | Other subject |
26 Jan 2024 17:59 CET |
RECTICEL | Participatiemelding van Janus Henderson Group plc | 50203015 Plastics | Other subject |
26 Jan 2024 17:59 CET |
RECTICEL | Participation notification by Janus Henderson Group plc | 50203015 Plastics | Other subject |
26 Jan 2024 17:40 CET |
KBC ANCORA ord | Halfjaarlijks financieel verslag 2023/2024 | 30101010 Banks | Income |
26 Jan 2024 17:40 CET |
KBC ANCORA ord | Interim Financial Report 2023/2024 | 30101010 Banks | Income |
26 Jan 2024 17:40 CET |
KBC ANCORA ord | Rapport financier semestriel 2023/2024 | 30101010 Banks | Income |
26 Jan 2024 08:15 CET |
BEKAERT | Bekaert - Mise à jour relative au Programme de Rachat d’Actions | 55102010 Iron and Steel | Legal |
26 Jan 2024 08:15 CET |
BEKAERT | Bekaert - Update over het Inkoopprogramma van Eigen Aandelen | 55102010 Iron and Steel | Legal |
26 Jan 2024 08:15 CET |
BEKAERT | Bekaert - Update on the Share Buyback Program | 55102010 Iron and Steel | Legal |
25 Jan 2024 23:11 CET |
ONWARD MEDICAL | ONWARD® ARC Therapy™ Highlighted at 2024 Annual Meeting of the North American Neuromodulation Society (NANS) | 20101025 Health Services | - |
25 Jan 2024 07:00 CET |
BIOSENIC | BioSenic présente de nouvelles données de phase 3 sur JTA-004 pour le traitement de la douleur arthrosique sévère lors du congrès mondial de l'OARSI 2024 | 20103010 Biotechnology | Corporate life |
25 Jan 2024 07:00 CET |
BIOSENIC | BioSenic presents new Phase 3 data on JTA-004 to treat severe osteoarthritis pain at the 2024 OARSI World Congress | 20103010 Biotechnology | Corporate life |
24 Jan 2024 19:04 CET |
PAYTON PLANAR MAGNETICS | PR dividend | 50202010 Electrical Components | Dividend |
23 Jan 2024 08:39 CET |
TITAN CEMENT | Programme de rachats d'actions | 50101030 Cement | Other subject |
23 Jan 2024 08:38 CET |
TITAN CEMENT | Share buyback programme | 50101030 Cement | Other subject |
23 Jan 2024 08:30 CET |
CIE BOIS SAUVAGE | Cie du Bois Sauvage: Buy back of own shares – week from 15/01/2024 to 19/01/2024 | 30202010 Asset Managers and Custodians | Other subject |
23 Jan 2024 08:30 CET |
CIE BOIS SAUVAGE | Cie du Bois Sauvage : Rachat d’actions propres – semaine du 15/01/2024 au 19/01/2024 | 30202010 Asset Managers and Custodians | Other subject |
23 Jan 2024 08:30 CET |
CIE BOIS SAUVAGE | Cie du Bois Sauvage: Terugkoop van eigen aandelen – Week van 15/01/2024 tot 19/01/2024 | 30202010 Asset Managers and Custodians | Other subject |
23 Jan 2024 08:10 CET |
TITAN CEMENT | Publication d'une notification de transparence | 50101030 Cement | Other subject |
23 Jan 2024 08:09 CET |
TITAN CEMENT | Publication of a transparency notification | 50101030 Cement | Other subject |
23 Jan 2024 08:00 CET |
KBC | KBC Groupe: Mise à jour concernant le programme de rachat d’actions propres de KBC Groupe | 30101010 Banks | Other subject |
23 Jan 2024 08:00 CET |
KBC | KBC Groep: Update m.b.t. inkoopprogramma van KBC Groep voor eigen aandelen | 30101010 Banks | Other subject |
23 Jan 2024 08:00 CET |
KBC | KBC Group: Update regarding the KBC Group share buyback programme | 30101010 Banks | Other subject |
23 Jan 2024 07:00 CET |
ION BEAM APPLICATIONS | iThemba LABS ready to start production of Strontium-82 and Germanium-68 using IBA Cyclone® 70 | 20102010 Medical Equipment | Other subject |
23 Jan 2024 07:00 CET |
BIOSENIC | BioSenic dépose une demande de protection supplémentaire par brevet, suite à de nouvelles preuves cliniques de l'efficacité de JTA-004 dans le traitement de l'arthrose | 20103010 Biotechnology | Corporate life |
23 Jan 2024 07:00 CET |
ION BEAM APPLICATIONS | iThemba LABS prêt à produire du strontium-82 et du germanium-68 avec un Cyclone® 70 d'IBA | 20102010 Medical Equipment | Other subject |
23 Jan 2024 07:00 CET |
BIOSENIC | BioSenic files for additional patent protection following new clinical evidence of efficacy for JTA-004 in osteoarthritis | 20103010 Biotechnology | Corporate life |
22 Jan 2024 22:02 CET |
OXURION | Oxurion Announces New Strategic Orientation to De-risk and Diversify | 20103010 Biotechnology | - |
22 Jan 2024 20:03 CET |
ONWARD MEDICAL | ONWARD® to Participate in Basel Healthtech Conference 2024 | 20101025 Health Services | - |
22 Jan 2024 18:05 CET |
GBL | GBL - Transacties op GBL-aandelen 22-01-2024 | 30202000 Diversified Financial Services | Other financial transaction |
22 Jan 2024 18:04 CET |
GBL | GBL - Transactions sur actions propres 22-01-2024 | 30202000 Diversified Financial Services | Other financial transaction |
22 Jan 2024 18:03 CET |
GBL | GBL - Transactions on GBL shares 22-01-2024 | 30202000 Diversified Financial Services | Other financial transaction |
22 Jan 2024 18:00 CET |
BIOTALYS NV | Biotalys Notice of Full Year 2023 Results and Business Highlights | 55201015 Fertilizers | - |
22 Jan 2024 17:45 CET |
KINEPOLIS GROUP | Update inkoopprogramma eigen aandelen (22 januari 2024) | 40301010 Entertainment | Corporate life |
22 Jan 2024 17:45 CET |
KINEPOLIS GROUP | Update share buyback program (22 January 2024) | 40301010 Entertainment | Corporate life |
22 Jan 2024 17:45 CET |
KINEPOLIS GROUP | Mise à jour concernant le programme de rachat d'actions propres (22 janvier 2024) | 40301010 Entertainment | Corporate life |
22 Jan 2024 17:40 CET |
AGEAS | Nouvelle composition de l’Executive Committee d'Ageas | 30301010 Life Insurance | - |
22 Jan 2024 17:40 CET |
AGEAS | Nieuwe samenstelling van Ageas’ Executive Committee | 30301010 Life Insurance | - |